Cartalax
Bioregulatory Tripeptide | Cartilage & Connective Tissue Support
Synthetic tripeptide developed by Professor Vladimir Khavinson, supporting cartilage, connective tissue, and cellular regeneration through proliferation markers and apoptosis pathway modulation.
Mechanism of Action
Modulates cell proliferation, suppresses apoptosis, affects fibroblast activity, reduces senescence markers, and influences extracellular matrix preservation.
Key Benefits
- Joint and connective tissue support
- Potential anti-aging effects on fibroblasts
- Cartilage regeneration support
- Established safety profile in Russian clinical practice
AE?Alanine
Position 1
Glutamic Acid
Position 2
Asp (AED)
Position 3
Joint Health
- Osteoarthritis
Clinical efficacy shown in osteochondrosis, osteoarthritis, and osteoporosis treatment.
- Degenerative Joint Disease Prevention
Supports cartilage maintenance and joint function.
- Post-Fracture Recovery
Supports bone and connective tissue healing.
Skin Health
- Fibroblast Activation
Increased Ki-67 expression with suppressed apoptosis in young and aged cells.
- Collagen Production
Enhances collagen synthesis in connective tissue.
- Cellular Senescence Reduction
Inhibited MMP-9 synthesis; maintained extracellular matrix integrity.
Capsule form; do not chew, swallow whole with water during meals.
| Goal | Dose | Frequency | Route |
|---|---|---|---|
| Joint Support | 100-200mcg (1-2 capsules) | 1-2x daily with meals | Oral |
Complementary bioregulatory effects across organ systems.
May enhance synthesis while supplements provide raw materials.
Different mechanisms; no direct interaction.
Distinct action pathways; may complement effects.
Both affect tissue growth; monitor for excessive proliferation.
Complementary joint support mechanisms.
Establishing baseline; minimal noticeable changes
Gradual improvement in joint comfort
Noticeable mobility improvements
Maximum therapeutic effect achieved
Common Side Effects
- No reported side effects in Russian clinical use when taken properly
- Well-tolerated in elderly patients
Stop Signs - Discontinue if:
- Allergic reactions
- Digestive upset (rare with proper administration)
- No improvement after 3 months
- Unexpected symptoms
Contraindications
- Pregnancy and breastfeeding
- Active cancer (theoretical proliferation risk)
Good Signs
- Professional Russian packaging with holographic seals
- Exactly 0.1mg (100mcg) AC-4 peptide complex per capsule
- Clear Russian/English instructions specifying 'with meals'
Warning Signs
- Proper documentation required for authenticity
- Import verification needed
Bad Signs
- Missing holographic seals or professional packaging
- Unclear dosing instructions
- Fibroblast Proliferation Study(2019)
Human skin fibroblasts; 72 hours at 20 nM. Increased Ki-67 expression with suppressed apoptosis in young and aged cells.
- Kidney Cell Culture Research(2020)
Renal epithelial cells; 7 days. Reduced pro-apoptotic p53 expression in aging kidney cells.
- Clinical Spine & Joint Study (Russia)(N/A)
Human subjects; 1-3 months with 0.1mg capsules daily. Efficacy in osteochondrosis, osteoarthritis, and osteoporosis treatment.
- Matrix Metalloproteinase Research(2020)
Fibroblast cultures; 5 days at 20 nM. Inhibited MMP-9 synthesis; maintained extracellular matrix integrity.
Disclaimer
This information is for educational and research purposes only. Consult a healthcare professional before use.